SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair - GZTR -- Ignore unavailable to you. Want to Upgrade?


To: KLH who wrote (238)8/29/1999 2:06:00 PM
From: jjs_ynot  Read Replies (1) | Respond to of 405
 
Does anyone on this thread know anything about the details of the Carticel procedure?

I have a daughter with significant cartilage damage/removal on her Femur from a fall and need some real information.

No spams please.



To: KLH who wrote (238)8/31/1999 12:37:00 PM
From: Exacctnt  Read Replies (1) | Respond to of 405
 
Karl, No exchanging shares today. Good news for a change.
biz.yahoo.com

Big volume, but the shares are trading in a wide range.



To: KLH who wrote (238)8/31/1999 12:49:00 PM
From: Exacctnt  Read Replies (1) | Respond to of 405
 
Karl, ATIS, a competitor, announced a similar improvement in treating foot ulcers.

biz.yahoo.com

I wonder which company has the advantage, if any, for FDA submission.

Regards